Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Alternating Current Electrophoretic Deposition for the Immobilization of Antimicrobial Agents on Titanium Implant Surfaces.

Braem A, De Brucker K, Delattin N, Killian MS, Roeffaers MB, Yoshioka T, Hayakawa S, Schmuki P, Cammue BP, Virtanen S, Thevissen K, Neirinck B.

ACS Appl Mater Interfaces. 2017 Mar 15;9(10):8533-8546. doi: 10.1021/acsami.6b16433. Epub 2017 Mar 6.

PMID:
28211996
2.

Modulation of the Substitution Pattern of 5-Aryl-2-Aminoimidazoles Allows Fine-Tuning of Their Antibiofilm Activity Spectrum and Toxicity.

Peeters E, Hooyberghs G, Robijns S, Waldrant K, De Weerdt A, Delattin N, Liebens V, Kucharíková S, Tournu H, Verstraeten N, Dovgan B, Girandon L, Fröhlich M, De Brucker K, Van Dijck P, Michiels J, Cammue BP, Thevissen K, Vanderleyden J, Van der Eycken E, Steenackers HP.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6483-6497. doi: 10.1128/AAC.00035-16. Print 2016 Nov.

3.

Antimicrobial Peptides as a Strategy to Combat Fungal Biofilms.

Delattin N, Brucker K, Cremer K, Cammue BP, Thevissen K.

Curr Top Med Chem. 2017;17(5):604-612. Review.

PMID:
27411323
4.

Covalent immobilization of antimicrobial agents on titanium prevents Staphylococcus aureus and Candida albicans colonization and biofilm formation.

Kucharíková S, Gerits E, De Brucker K, Braem A, Ceh K, Majdič G, Španič T, Pogorevc E, Verstraeten N, Tournu H, Delattin N, Impellizzeri F, Erdtmann M, Krona A, Lövenklev M, Knezevic M, Fröhlich M, Vleugels J, Fauvart M, de Silva WJ, Vandamme K, Garcia-Forgas J, Cammue BP, Michiels J, Van Dijck P, Thevissen K.

J Antimicrob Chemother. 2016 Apr;71(4):936-45. doi: 10.1093/jac/dkv437. Epub 2015 Dec 24.

PMID:
26702917
5.

Combinatorial drug approaches to tackle Candida albicans biofilms.

De Cremer K, Staes I, Delattin N, Cammue BP, Thevissen K, De Brucker K.

Expert Rev Anti Infect Ther. 2015 Aug;13(8):973-84. doi: 10.1586/14787210.2015.1056162. Epub 2015 Jun 12. Review.

PMID:
26070384
6.

Novel anti-infective implant substrates: controlled release of antibiofilm compounds from mesoporous silica-containing macroporous titanium.

Braem A, De Cremer K, Delattin N, De Brucker K, Neirinck B, Vandamme K, Martens JA, Michiels J, Vleugels J, Cammue BP, Thevissen K.

Colloids Surf B Biointerfaces. 2015 Feb 1;126:481-8. doi: 10.1016/j.colsurfb.2014.12.054. Epub 2015 Jan 7.

PMID:
25601097
7.

Evaluation of the toxicity of 5-aryl-2-aminoimidazole-based biofilm inhibitors against eukaryotic cell lines, bone cells and the nematode Caenorhabditis elegans.

Steenackers H, Dubey A, Robijns S, Ermolat'ev D, Delattin N, Dovgan B, Girandon L, Fröhlich M, De Brucker K, Cammue BP, Thevissen K, Balzarini J, Van der Eycken EV, Vanderleyden J.

Molecules. 2014 Oct 16;19(10):16707-23. doi: 10.3390/molecules191016707.

8.

Oral administration of the broad-spectrum antibiofilm compound toremifene inhibits Candida albicans and Staphylococcus aureus biofilm formation in vivo.

De Cremer K, Delattin N, De Brucker K, Peeters A, Kucharíková S, Gerits E, Verstraeten N, Michiels J, Van Dijck P, Cammue BP, Thevissen K.

Antimicrob Agents Chemother. 2014 Dec;58(12):7606-10. doi: 10.1128/AAC.03869-14. Epub 2014 Oct 6.

9.

Derivatives of the mouse cathelicidin-related antimicrobial peptide (CRAMP) inhibit fungal and bacterial biofilm formation.

De Brucker K, Delattin N, Robijns S, Steenackers H, Verstraeten N, Landuyt B, Luyten W, Schoofs L, Dovgan B, Fröhlich M, Michiels J, Vanderleyden J, Cammue BP, Thevissen K.

Antimicrob Agents Chemother. 2014 Sep;58(9):5395-404. doi: 10.1128/AAC.03045-14. Epub 2014 Jun 30.

10.

Structure-activity relationship study of the plant-derived decapeptide OSIP108 inhibiting Candida albicans biofilm formation.

Delattin N, De Brucker K, Craik DJ, Cheneval O, De Coninck B, Cammue BP, Thevissen K.

Antimicrob Agents Chemother. 2014 Aug;58(8):4974-7. doi: 10.1128/AAC.03336-14. Epub 2014 Jun 9.

11.

Synergistic activity of the tyrocidines, antimicrobial cyclodecapeptides from Bacillus aneurinolyticus, with amphotericin B and caspofungin against Candida albicans biofilms.

Troskie AM, Rautenbach M, Delattin N, Vosloo JA, Dathe M, Cammue BP, Thevissen K.

Antimicrob Agents Chemother. 2014 Jul;58(7):3697-707. doi: 10.1128/AAC.02381-14. Epub 2014 Apr 21.

12.

Plant-derived decapeptide OSIP108 interferes with Candida albicans biofilm formation without affecting cell viability.

Delattin N, De Brucker K, Craik DJ, Cheneval O, Fröhlich M, Veber M, Girandon L, Davis TR, Weeks AE, Kumamoto CA, Cos P, Coenye T, De Coninck B, Cammue BP, Thevissen K.

Antimicrob Agents Chemother. 2014 May;58(5):2647-56. doi: 10.1128/AAC.01274-13. Epub 2014 Feb 24.

13.

Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms.

Delattin N, Cammue BP, Thevissen K.

Future Med Chem. 2014 Jan;6(1):77-90. doi: 10.4155/fmc.13.189. Review.

14.

Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.

Delattin N, De Brucker K, Vandamme K, Meert E, Marchand A, Chaltin P, Cammue BP, Thevissen K.

J Antimicrob Chemother. 2014 Apr;69(4):1035-44. doi: 10.1093/jac/dkt449. Epub 2013 Nov 27.

PMID:
24284780
15.

Identification of fungicidal 2,6-disubstituted quinolines with activity against Candida biofilms.

Delattin N, Bardiot D, Marchand A, Chaltin P, De Brucker K, Cammue BP, Thevissen K.

Molecules. 2012 Oct 18;17(10):12243-51. doi: 10.3390/molecules171012243.

16.

VEGF mediates commissural axon chemoattraction through its receptor Flk1.

Ruiz de Almodovar C, Fabre PJ, Knevels E, Coulon C, Segura I, Haddick PC, Aerts L, Delattin N, Strasser G, Oh WJ, Lange C, Vinckier S, Haigh J, Fouquet C, Gu C, Alitalo K, Castellani V, Tessier-Lavigne M, Chedotal A, Charron F, Carmeliet P.

Neuron. 2011 Jun 9;70(5):966-78. doi: 10.1016/j.neuron.2011.04.014.

Supplemental Content

Loading ...
Support Center